MPO and metabolic dysfunction-associated steatotic liver disease: Moreover, neutrophil effectors such as elastase (NE), myeloperoxidase (MPO), and human neutrophil peptides (HNP-1) have been shown to exacerbate liver inflammation, IR, steatosis, and fibrosis in MASLD [71,72].